6 / 13
Anton Bzhelyansky
USP
MURALI BALASURAMANIAN NATURAL REMEDIES
Premal Bhatt
USP
Nour Eddine ES‐SAFI
Mohammed V University in Rabat
Prashant Ingle
Herbalife
Tom Phillips
State of Maryland
Catherine Rimmer
NIST
Casey Sayre
Roseman University of Health Sciences
Aniko Solyom
GAAS Analytical
Darryl Sullivan
Covance
Kurt Young
GNC/Nutra Manufacturing
Yanjun Zhang
Herbalife
16%
17%
50%
17%
Ashwagandha ‐ By Broad Perspectives
ACADEMIA GOVERNMENT INDUSTRY NGO
9%
8%
Ashwagandha ‐ By Region
USA INDIA MOROCCO
17%
33%
25%
8%
17%
Ashwagandha ‐ By Specific Perspectives
CRO MANUFACTURER REFERENCE MATERIALS REGULATOR RESEARCH
83%
ASHWAGANDHA